Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectafer in cancer and chemotherapy related anemia
NCT02453334Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- May 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in anemia, sponsored by American Regent, Inc.. Started May 2015; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02453334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453334.